CRISPR THERAPEUTIC earnings per share and revenue

1CG earnings per share for the last quarter are -0.86 CHF whereas the estimation was -1.17 CHF which accounts for 27.06% surprise. Company revenue for the same period amounts to 510.15 k CHF despite the estimated figure of 5.57 M CHF. Estimated earnings per share for the next quarter are -1.10 CHF, and revenue is expected to reach 7.92 M CHF. Also watch annual changes over time to get a bigger picture of 1CG earnings per share and revenue dynamics.